(Q52564588)

English

The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

title

The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors. (English)

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

author name string

Dietmar W Siemann

series ordinal

1

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

Amyn M Rojiani

series ordinal

2

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

language of work or name

English

0 references

publication date

1 July 2005

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

published in

International Journal of Radiation Oncology Biology Physics

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

volume

62

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

issue

3

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

page(s)

846-853

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

Identifiers

DOI

10.1016/J.IJROBP.2005.02.048

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

Fatcat ID

release_3ehqfpoayjf7benyvfrh4dnpye

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/3ehqfpoayjf7benyvfrh4dnpye

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

15936569

1 reference

stated in

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/15936569

(Q52564588)

The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)